Factory high quality and low price 5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine
Price | USD1.00 |
Packge | 1g |
- Min. Order:1g
- Supply Ability:g/kg/Ton
- Time:2019-12-26
Product Details
- Product Name5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine
- CAS No.192314-93-5
- EINECS No.606-269-6
- MFC19H22N4O3
- MW354.4
- AppearanceSolidWhite to off-white
- Boiling point 616.7±65.0 °C(Predicted)
- density 1.332±0.06 g/cm3(Predicted)
- Water Solubility 14g/L at 20℃
- storage temp. Store at -20°C
Heidi 0702
Email:heidi@coreychem.com
▼
▲
5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine Basic information
▼
▲
Synonyms:
5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine;iclaprim;5-[(2-Cyclopropyl-7,8-diMethoxy-2H-1-benzopyran-5-yl)Methyl]-2,4-pyriMidine- diaMine;AR 100;5-(2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-ylmethyl)-pyrimidine-2,4-diamine (ICLAPRIM];5-((2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl)pyrimidine-2,4-diamine(WXG01982)
CAS:
MF:
C19H22N4O3
MW:
354.408
EINECS:
Product Categories:
Mol File:
▼
▲
5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine Chemical Properties
▼
▲
Boiling point
616.7±65.0 °C(Predicted)
density
1.332±0.06 g/cm3(Predicted)
pka
7.07±0.10(Predicted)
▼
▲
Safety Information
▼
▲
▼
▲
5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine Usage And Synthesis
▼
▲
Uses
Iclaprim is a novel antibacterial agent that is currently in development for the treatment of complicated skin and skin structure infections (cSSSI).
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY